Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth B Margulies

Showing results (231-240 of 265) with videos related to

Pageof 27
Sort By:
Hypertension (Dallas, Tex. : 1979)|May 20, 2026
Cluster Randomized Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191Bonnie Ky, Tao Liu, Kenneth B Margulies, et al.
Nature|September 13, 2019
Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.
Research Square|December 4, 2023
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Nathan Youlton, et al.
Circulation Research|June 13, 2020
Epigenomes of Human Hearts Reveal New Genetic Variants Relevant for Cardiac Disease and PhenotypeWilson Lek Wen Tan, Chukwuemeka George Anene-Nzelu, Eleanor Wong, et al.
Nature Cardiovascular Research|June 5, 2025
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Michelle Youlton, et al.
The Journal of Clinical Investigation|February 20, 2018
A common variant alters SCN5A-miR-24 interaction and associates with heart failure mortalityXiaoming Zhang, Jin-Young Yoon, Michael Morley, et al.
Nature Medicine|February 14, 2017
Sirtuin 1 regulates cardiac electrical activity by deacetylating the cardiac sodium channelAjit Vikram, Christopher M Lewarchik, Jin-Young Yoon, et al.
Circulation. Heart Failure|October 18, 2024
Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection FractionSenthil Selvaraj, Shachi Patel, Andrew J Sauer, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Nathan Youlton, et al.
Circulation|May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyMichael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.
Pageof 27

Showing results (231-240 of 265) with videos related to

Sort By:
Pageof 27
Hypertension (Dallas, Tex. : 1979)|May 20, 2026
Cluster Randomized Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191Bonnie Ky, Tao Liu, Kenneth B Margulies, et al.
Nature|September 13, 2019
Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.
Research Square|December 4, 2023
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Nathan Youlton, et al.
Circulation Research|June 13, 2020
Epigenomes of Human Hearts Reveal New Genetic Variants Relevant for Cardiac Disease and PhenotypeWilson Lek Wen Tan, Chukwuemeka George Anene-Nzelu, Eleanor Wong, et al.
Nature Cardiovascular Research|June 5, 2025
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Michelle Youlton, et al.
The Journal of Clinical Investigation|February 20, 2018
A common variant alters SCN5A-miR-24 interaction and associates with heart failure mortalityXiaoming Zhang, Jin-Young Yoon, Michael Morley, et al.
Nature Medicine|February 14, 2017
Sirtuin 1 regulates cardiac electrical activity by deacetylating the cardiac sodium channelAjit Vikram, Christopher M Lewarchik, Jin-Young Yoon, et al.
Circulation. Heart Failure|October 18, 2024
Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection FractionSenthil Selvaraj, Shachi Patel, Andrew J Sauer, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Nathan Youlton, et al.
Circulation|May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyMichael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.
Pageof 27